Research Article

Epidemiological and survival profile of laryngeal cancer patients recorded in the database of Ege University Medical School

October 26, 2020
  • Göksel Turhal
  • Fetih Furkan Şahin *
  • Kerem Öztürk
  • Özlem Akagündüz
  • Serdar Akyıldız
  • Mustafa Esassolak Esassolak
  • Ümit Uluöz
  • Ali Veral
  • Ulus Ali Şanlı
  • Ayşe Caner
EN TR

Epidemiological and survival profile of laryngeal cancer patients recorded in the database of Ege University Medical School

Abstract

Aim: The scope of this study was to investigate the demographic characteristics of laryngeal cancer and the factors that may effect the overall survival of laryngeal cancer in patients recorded in Ege University Cancer and Research Center (EUKAM) database.

Materials and Methods: Data of 3144 laryngeal cancer patients registered at EUKAM between 1992-2016; diagnosis, age, gender, histopathology, tumor stage, treatment modalities, follow-up period and latest status were retrospectively evaluated.

Results: The average age of 3144 patients was 59.4±10.5 years. 94.9% of the cases were male and 5.1% were female. The most common histopathological type was carcinoma with the percentage of 97.4%, and the most common stage was locally limited with the percentage of 47.1%. The 5, 10, 15 and 20-year overall survival rates were 67%, 48.6%, 33.8% and 23.5%, respectively.

Conclusion: Tumor stage and age were found to be significantly effective on survival of laryngeal cancers, on the other hand gender did not have a significant effect on survival. In last decades there has been an increase in alternative options and success rates in larynx preservation treatment modalities in recent years, as well as an increase in the incidence of laryngeal cancer.

Keywords

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6);394-424.
  2. Surveillance, Epidemiology and End Result Program. Cancer stat facts: Laryngeal cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/laryn.html
  3. Survival Rates for Laryngeal and Hypopharyngeal Cancers. American Cancer Society. https://www.cancer.org/cancer/laryngeal-and-hypopharyngeal-cancer/detection-diagnosis-staging/survival-rates.html
  4. Koç C. Kulak Burun Boğaz Hastalıkları ve Baş Boyun Cerrahisi. 1. Baskı, Ankara: Güneş Kitabevi Ltd Şti, 2003; 1183-216.
  5. Wunsch Filho V. The epidemiology of laryngeal cancer in Brazil. Sao Paulo Med J. 2004 Sep 2;122(5):188-94.
  6. Koufman JA, Burke AJ. The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am 1997; 30: 1-19.
  7. Dagli S, Dagli U, Kurtaran H, Alkim C, Sahin B. Laryngopharyngeal reflux in laryngeal cancer. Turk J Gastroenterol. 2004 Jun;15(2):77-81.
  8. Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. Squamous cell carcinoma of the glottic larynx: a review emphasizing the University of Florida philosophy. Review. South Med J. 1999 Apr;92(4):385-93.

Details

Primary Language

Turkish

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Göksel Turhal
0000-0003-0020-1921
Türkiye

Fetih Furkan Şahin *
0000-0002-6593-9452
Türkiye

Kerem Öztürk
0000-0003-2754-4166
Türkiye

Özlem Akagündüz
0000-0002-5438-9969
Türkiye

Serdar Akyıldız
0000-0002-7472-5499
Türkiye

Mustafa Esassolak Esassolak
0000-0001-7512-8015
Türkiye

Ümit Uluöz
0000-0001-7498-5963
Türkiye

Ali Veral
0000-0003-0343-9978
Türkiye

Ulus Ali Şanlı
0000-0002-0062-6105
Türkiye

Ayşe Caner
0000-0003-3058-9971
Türkiye

Publication Date

October 26, 2020

Submission Date

August 28, 2020

Acceptance Date

October 5, 2020

Published in Issue

Year 1970

Vancouver
1.Göksel Turhal, Fetih Furkan Şahin, Kerem Öztürk, Özlem Akagündüz, Serdar Akyıldız, Mustafa Esassolak Esassolak, Ümit Uluöz, Ali Veral, Ulus Ali Şanlı, Ayşe Caner. Ege Üniversitesi Hastanesi veri tabanında kayıtlı larinks kanserli olguların epidemiyolojik ve genel sağkalım özellikleri. EJM. 2020 Oct. 1;47-53. doi:10.19161/etd.815296

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.